N-Nitroso Paroxetine Impurity
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Paroxetine is a selective serotonin reuptake inhibitor (SSRI). It is used to treat several diseases, including major depressive disorder,obsessive-compulsive disorder, social anxiety disorder, panic disorder, posttraumatic stress disorder, generalized anxiety disorder, and premenstrual dysphoric disorder.N-Nitroso Paroxetine is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Paroxetine chemically represented as (3S,4R)-3-((Benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1- nitrosopiperidine .Synchemia is the leading manufacturing and exporter of N-Nitroso Paroxetine . We supply N-Nitroso Paroxetine with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143205 |
| CAS No | NA |
| Mol.F. | C30H31N9O9S |
| Mol.Wt. | 693.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143206 |
| CAS No | NA |
| Mol.F. | C45H49ClN8O9S |
| Mol.Wt. | 913.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143207 |
| CAS No | NA |
| Mol.F. | C45H49ClN8O9S |
| Mol.Wt. | 913.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143208 |
| CAS No | NA |
| Mol.F. | C45H51ClN8O6S |
| Mol.Wt. | 867.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143209 |
| CAS No | NA |
| Mol.F. | C45H49ClN8O9S |
| Mol.Wt. | 913.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143210 |
| CAS No | NA |
| Mol.F. | C47H51ClN8O9S |
| Mol.Wt. | 939.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143211 |
| CAS No | NA |
| Mol.F. | C45H49ClN8O9S |
| Mol.Wt. | 913.44 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143212 |
| CAS No | NA |
| Mol.F. | C20H31N7OS2 |
| Mol.Wt. | 449.64 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143213 |
| CAS No | NA |
| Mol.F. | C21H33N7OS2 |
| Mol.Wt. | 463.66 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143214 |
| CAS No | NA |
| Mol.F. | C21H33N7OS2 |
| Mol.Wt. | 463.66g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143215 |
| CAS No | NA |
| Mol.F. | C11H16N4OS |
| Mol.Wt. | 252.34 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143216 |
| CAS No | NA |
| Mol.F. | C11H18N4O2S |
| Mol.Wt. | 270.35g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143217 |
| CAS No | NA |
| Mol.F. | C10H18N4O3S |
| Mol.Wt. | 274.34 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143218 |
| CAS No | NA |
| Mol.F. | C15H24N4O5S |
| Mol.Wt. | 372.44 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143219 |
| CAS No | NA |
| Mol.F. | C10H16N4O2S |
| Mol.Wt. | 256.32 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143220 |
| CAS No | NA |
| Mol.F. | C20H31N7OS2 |
| Mol.Wt. | 449.64 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |